<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:vavx="http://www.vaneck.com/20260930"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="vavx-20260930.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2026-10-31</instant>
        </period>
    </context>
    <context id="c2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2026-07-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <instant>2026-06-30</instant>
        </period>
    </context>
    <context id="c7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:QuantityOfAvalancheMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-19</instant>
        </period>
    </context>
    <context id="c21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-19</instant>
        </period>
    </context>
    <context id="c22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:PortionAtFairValueFairValueDisclosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="c24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2026-02-28</endDate>
        </period>
    </context>
    <context id="c25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-20</startDate>
            <endDate>2025-11-20</endDate>
        </period>
    </context>
    <context id="c26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-11-20</instant>
        </period>
    </context>
    <context id="c27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-22</instant>
        </period>
    </context>
    <context id="c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCreationBasketsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-12-22</startDate>
            <endDate>2025-12-22</endDate>
        </period>
    </context>
    <context id="c29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vavx:SeedCapitalInvestorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="c31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">vavx:VanEckSecuritiesCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-09-30</instant>
        </period>
    </context>
    <context id="c32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">vavx:QuantityOfAvaxMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vavx:NoncoLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">vavx:NoncoLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">vavx:SecondaryMarketMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-09-30</endDate>
        </period>
    </context>
    <context id="c35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">vavx:O2026Q4DividendsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-10-05</instant>
        </period>
    </context>
    <context id="c36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002060717</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DividendsAxis">vavx:O2026Q4DividendsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-10-05</startDate>
            <endDate>2026-10-05</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPershares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Avalanche">
        <measure>vavx:Avalanche</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Segment">
        <measure>vavx:Segment</measure>
    </unit>
    <dei:DocumentType contextRef="c0" id="ixv-3655">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="c0" id="ixv-45">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="c0" id="ixv-3656">2026-09-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="c0" id="ixv-3657">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="c0" id="ixv-62">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c0" id="ixv-3658">001-43064</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-83">VanEck Avalanche ETF</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-101">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c0" id="ixv-106">33-6867966</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c0" id="ixv-3659">666 Third Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c0" id="ixv-128">9th Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c0" id="ixv-3660">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c0" id="ixv-3661">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c0" id="ixv-3662">10017</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c0" id="ixv-3663">212</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c0" id="ixv-3664">293-2000</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c0" id="ixv-170">Shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c0" id="ixv-175">VAVX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c0" id="ixv-180">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="c0" id="ixv-3665">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c0" id="ixv-3666">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-223">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-231">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-237">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-247">true</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="c0" id="ixv-256">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="c1"
      decimals="INF"
      id="ixv-3667"
      unitRef="shares">1000000</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CryptoAssetCost contextRef="c2" decimals="0" id="ixv-3668" unitRef="usd">18984097</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetCost contextRef="c3" decimals="0" id="ixv-3669" unitRef="usd">2500000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue contextRef="c2" decimals="0" id="ixv-3670" unitRef="usd">22064999</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ixv-3671" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:Assets contextRef="c2" decimals="0" id="ixv-3672" unitRef="usd">22064999</us-gaap:Assets>
    <us-gaap:Assets contextRef="c3" decimals="0" id="ixv-3673" unitRef="usd">2517563</us-gaap:Assets>
    <vavx:AccruedSponsorFee contextRef="c2" decimals="0" id="ixv-3674" unitRef="usd">7146</vavx:AccruedSponsorFee>
    <vavx:AccruedSponsorFee contextRef="c3" decimals="0" id="ixv-3675" unitRef="usd">0</vavx:AccruedSponsorFee>
    <us-gaap:Liabilities contextRef="c2" decimals="0" id="ixv-3676" unitRef="usd">7146</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c3" decimals="0" id="ixv-3677" unitRef="usd">0</us-gaap:Liabilities>
    <us-gaap:AssetsNet contextRef="c2" decimals="0" id="ixv-3678" unitRef="usd">22057853</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ixv-3679" unitRef="usd">2517563</us-gaap:AssetsNet>
    <us-gaap:CommonStockNoParValue
      contextRef="c2"
      decimals="INF"
      id="ixv-3680"
      unitRef="usdPershares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:CommonStockNoParValue
      contextRef="c3"
      decimals="INF"
      id="ixv-3681"
      unitRef="usdPershares">0</us-gaap:CommonStockNoParValue>
    <us-gaap:SharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ixv-3682"
      unitRef="shares">950000</us-gaap:SharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="c2"
      decimals="INF"
      id="ixv-3683"
      unitRef="shares">950000</us-gaap:SharesIssued>
    <us-gaap:SharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ixv-3684"
      unitRef="shares">100000</us-gaap:SharesOutstanding>
    <us-gaap:SharesIssued
      contextRef="c3"
      decimals="INF"
      id="ixv-3685"
      unitRef="shares">100000</us-gaap:SharesIssued>
    <us-gaap:NetAssetValuePerShare
      contextRef="c2"
      decimals="INF"
      id="ixv-3686"
      unitRef="usdPershares">23.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c3"
      decimals="INF"
      id="ixv-3687"
      unitRef="usdPershares">25.18</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentIncomeInterest contextRef="c5" decimals="0" id="ix_0_fact" unitRef="usd">145915</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest contextRef="c0" decimals="0" id="ix_1_fact" unitRef="usd">324163</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeNet contextRef="c5" decimals="0" id="ix_2_fact" unitRef="usd">145915</us-gaap:InvestmentIncomeNet>
    <us-gaap:InvestmentIncomeNet contextRef="c0" decimals="0" id="ix_3_fact" unitRef="usd">324163</us-gaap:InvestmentIncomeNet>
    <us-gaap:SponsorFees contextRef="c5" decimals="0" id="ix_4_fact" unitRef="usd">6562</us-gaap:SponsorFees>
    <us-gaap:SponsorFees contextRef="c0" decimals="0" id="ix_5_fact" unitRef="usd">16064</us-gaap:SponsorFees>
    <us-gaap:OperatingExpenses contextRef="c5" decimals="0" id="ix_6_fact" unitRef="usd">6562</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c0" decimals="0" id="ix_7_fact" unitRef="usd">16064</us-gaap:OperatingExpenses>
    <us-gaap:InvestmentCompanyExpenseOffsetArrangement contextRef="c5" decimals="0" id="ix_8_fact" unitRef="usd">0</us-gaap:InvestmentCompanyExpenseOffsetArrangement>
    <us-gaap:InvestmentCompanyExpenseOffsetArrangement contextRef="c0" decimals="0" id="ix_9_fact" unitRef="usd">956</us-gaap:InvestmentCompanyExpenseOffsetArrangement>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c5" decimals="0" id="ix_10_fact" unitRef="usd">6562</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement contextRef="c0" decimals="0" id="ix_11_fact" unitRef="usd">15108</us-gaap:InvestmentCompanyExpenseAfterReductionOfFeeWaiverAndReimbursement>
    <us-gaap:NetInvestmentIncome contextRef="c5" decimals="0" id="ix_12_fact" unitRef="usd">139353</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome contextRef="c0" decimals="0" id="ix_13_fact" unitRef="usd">309055</us-gaap:NetInvestmentIncome>
    <vavx:NetRealizedGainLossOnAvalancheSoldForRedemptionOfShares contextRef="c5" decimals="0" id="ix_14_fact" unitRef="usd">0</vavx:NetRealizedGainLossOnAvalancheSoldForRedemptionOfShares>
    <vavx:NetRealizedGainLossOnAvalancheSoldForRedemptionOfShares contextRef="c0" decimals="0" id="ix_15_fact" unitRef="usd">0</vavx:NetRealizedGainLossOnAvalancheSoldForRedemptionOfShares>
    <vavx:NetRealizedGainLossOnSoldForDistribution contextRef="c5" decimals="0" id="ix_16_fact" unitRef="usd">-52185</vavx:NetRealizedGainLossOnSoldForDistribution>
    <vavx:NetRealizedGainLossOnSoldForDistribution contextRef="c0" decimals="0" id="ix_17_fact" unitRef="usd">-52185</vavx:NetRealizedGainLossOnSoldForDistribution>
    <vavx:NetRealizedGainLossOnSoldToPayExpenses contextRef="c5" decimals="0" id="ix_18_fact" unitRef="usd">-4276</vavx:NetRealizedGainLossOnSoldToPayExpenses>
    <vavx:NetRealizedGainLossOnSoldToPayExpenses contextRef="c0" decimals="0" id="ix_19_fact" unitRef="usd">-4892</vavx:NetRealizedGainLossOnSoldToPayExpenses>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c5" decimals="0" id="ix_20_fact" unitRef="usd">-56461</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c0" decimals="0" id="ix_21_fact" unitRef="usd">-57077</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c5" decimals="0" id="ix_22_fact" unitRef="usd">8046314</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c0" decimals="0" id="ix_23_fact" unitRef="usd">3063339</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating contextRef="c5" decimals="0" id="ix_24_fact" unitRef="usd">7989853</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating contextRef="c0" decimals="0" id="ix_25_fact" unitRef="usd">3006262</us-gaap:CryptoAssetRealizedAndUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" id="ix_26_fact" unitRef="usd">8129206</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ix_27_fact" unitRef="usd">3315317</us-gaap:NetIncomeLoss>
    <us-gaap:NetInvestmentIncome contextRef="c5" decimals="0" id="ix_28_fact" unitRef="usd">139353</us-gaap:NetInvestmentIncome>
    <us-gaap:NetInvestmentIncome contextRef="c0" decimals="0" id="ix_29_fact" unitRef="usd">309055</us-gaap:NetInvestmentIncome>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c5" decimals="0" id="ix_30_fact" unitRef="usd">-56461</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c0" decimals="0" id="ix_31_fact" unitRef="usd">-57077</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c5" decimals="0" id="ix_32_fact" unitRef="usd">8046314</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c0" decimals="0" id="ix_33_fact" unitRef="usd">3063339</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <us-gaap:NetIncomeLoss contextRef="c5" decimals="0" id="ix_34_fact" unitRef="usd">8129206</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c0" decimals="0" id="ix_35_fact" unitRef="usd">3315317</us-gaap:NetIncomeLoss>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c5" decimals="0" id="ixv-3725" unitRef="usd">140003</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:InvestmentCompanyDividendDistribution contextRef="c0" decimals="0" id="ixv-3726" unitRef="usd">140003</us-gaap:InvestmentCompanyDividendDistribution>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c5" decimals="0" id="ix_36_fact" unitRef="usd">2505622</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="0" id="ix_37_fact" unitRef="usd">16364976</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c5" decimals="0" id="ix_38_fact" unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:StockRepurchasedAndRetiredDuringPeriodValue contextRef="c0" decimals="0" id="ix_39_fact" unitRef="usd">0</us-gaap:StockRepurchasedAndRetiredDuringPeriodValue>
    <us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction contextRef="c5" decimals="0" id="ix_40_fact" unitRef="usd">2505622</us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction>
    <us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction contextRef="c0" decimals="0" id="ix_41_fact" unitRef="usd">16364976</us-gaap:InvestmentCompanyIncreaseDecreaseFromShareTransaction>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c5" decimals="0" id="ix_42_fact" unitRef="usd">10494825</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:IncreaseDecreaseInOperatingCapital contextRef="c0" decimals="0" id="ix_43_fact" unitRef="usd">19540290</us-gaap:IncreaseDecreaseInOperatingCapital>
    <us-gaap:AssetsNet contextRef="c6" decimals="0" id="ix_44_fact" unitRef="usd">11563028</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ix_45_fact" unitRef="usd">2517563</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c2" decimals="0" id="ix_46_fact" unitRef="usd">22057853</us-gaap:AssetsNet>
    <us-gaap:AssetsNet contextRef="c2" decimals="0" id="ix_47_fact" unitRef="usd">22057853</us-gaap:AssetsNet>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c2"
      decimals="INF"
      id="ix_48_fact"
      unitRef="Avalanche">1985601.68</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetCost contextRef="c2" decimals="0" id="ixv-3740" unitRef="usd">18984097</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue contextRef="c2" decimals="0" id="ixv-3741" unitRef="usd">22064999</us-gaap:CryptoAssetFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c2" decimals="INF" id="ixv-3742" unitRef="pure">1.0003</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c2" decimals="0" id="ixv-3743" unitRef="usd">22064999</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets contextRef="c2" decimals="INF" id="ixv-3744" unitRef="pure">-0.0003</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities contextRef="c2" decimals="0" id="ixv-3745" unitRef="usd">-7146</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <vavx:NetAssetsPercentageOfNetAssetsValue contextRef="c2" decimals="INF" id="ixv-3746" unitRef="pure">1</vavx:NetAssetsPercentageOfNetAssetsValue>
    <us-gaap:AssetsNet contextRef="c2" decimals="0" id="ixv-3747" unitRef="usd">22057853</us-gaap:AssetsNet>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c3"
      decimals="INF"
      id="ixv-3748"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetCost contextRef="c3" decimals="0" id="ixv-3749" unitRef="usd">2500000</us-gaap:CryptoAssetCost>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ixv-3750" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:InvestmentOwnedPercentOfNetAssets contextRef="c3" decimals="INF" id="ixv-3751" unitRef="pure">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss contextRef="c3" decimals="0" id="ixv-3752" unitRef="usd">2517563</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets contextRef="c3" decimals="INF" id="ixv-3753" unitRef="pure">0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilitiesPercentOfNetAssets>
    <us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities contextRef="c3" decimals="0" id="ixv-3754" unitRef="usd">0</us-gaap:NonInvestmentAssetsLessNonInvestmentLiabilities>
    <vavx:NetAssetsPercentageOfNetAssetsValue contextRef="c3" decimals="INF" id="ixv-3755" unitRef="pure">1</vavx:NetAssetsPercentageOfNetAssetsValue>
    <us-gaap:AssetsNet contextRef="c3" decimals="0" id="ixv-3756" unitRef="usd">2517563</us-gaap:AssetsNet>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c7"
      decimals="INF"
      id="ixv-3758"
      unitRef="Avalanche">1588636.97</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:NatureOfOperations contextRef="c0" id="ixv-1399">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Note 1&lt;/b&gt;&lt;/span&gt;&lt;b&gt;.&lt;span style="font-size: 10pt"&gt;
Organization&lt;/span&gt;:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VanEck Avalanche ETF (the &#x201c;Trust&#x201d;),
a Delaware statutory trust, is an exchange-traded fund that issues common shares of beneficial interest in the Trust (the &#x201c;Shares&#x201d;).
The Trust commenced operations on January 26, 2026. The Shares are traded on the Nasdaq Stock Market LLC (the &#x201c;Exchange&#x201d;).
The Trust&#x2019;s investment objective is to reflect the performance of the price of Avalanche (&#x201c;AVAX&#x201d;)&lt;span style="color: #E52138"&gt;
&lt;/span&gt;and rewards from staking a portion of the Trust&#x2019;s AVAX, to the extent VanEck Digital Assets, LLC (the &#x201c;Sponsor&#x201d;)
in its sole discretion determines that the Trust may do so without undue legal or regulatory risk, such as, without limitation,
by jeopardizing the Trust&#x2019;s ability to qualify as a grantor trust for tax purposes, less the operating expenses of the Trust. The
Trust is managed and controlled by the Sponsor, a wholly-owned subsidiary of Van Eck Associates Corporation (&#x201c;VanEck&#x201d;).
The CSC Delaware Trust Company, is the trustee of the Trust (the &#x201c;Trustee&#x201d;).&lt;/p&gt;</us-gaap:NatureOfOperations>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c0" id="ixv-1411">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Note 2. Significant Accounting Policies&lt;/b&gt;&lt;/span&gt;&lt;b&gt;:&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The preparation
of financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management
to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results
could differ from those estimates&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
qualifies as an investment company solely for accounting purposes and not for any other purpose and follows accounting and reporting
requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt;
&lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and is not required to be registered, as an investment company
under the Investment Company Act of 1940, as amended&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;B.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Cash, if any, represents cash deposits
held at a major financial institution and is subject to credit risk to the extent its balance exceeds the federally insured limits.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;C.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Investment Valuation&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
values its investment in AVAX and other assets and liabilities at fair value. Fair value is the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
identifies and determines the AVAX principal market (or in the absence of a principal market, the
most advantageous market) for GAAP financial statement purposes consistent with the application of fair value measurement framework
in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820 at 11:59 p.m. EST. Under ASC 820, a principal market is the
market with the greatest volume and activity level for the asset or liability. The Sponsor on behalf of the Trust will determine
in its sole discretion the valuation sources and policies used to prepare the Trust&#x2019;s financial statements in accordance
with GAAP.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Various
inputs are used in determining the fair value of assets and liabilities. Inputs may be based on independent market data or they
may be internally developed. These inputs are categorized into a disclosure hierarchy consisting of three broad levels for financial
reporting purposes. The three levels of the fair value hierarchy are as follows&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;Level 1 &#x2013;
Unadjusted quoted prices in active markets for identical assets or liabilities&lt;/span&gt;;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level
2 &#x2013; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly
or indirectly, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar
assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for
the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or
other means; and&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Level 3 &#x2013; Unobservable inputs
where there are little or no market activity for the asset or liability, including the Trust&#x2019;s assumptions used in determining
the fair value of investments.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following is
a summary of the fair value hierarchy as of September 30, 2026 and December 31, 2025&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0 0 0 29.6pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;September 30, 2026&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment
    in AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment in
    AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following represents
the changes in quantity of AVAX and the respective fair value&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of January 1, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;559,830.28 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,598,904 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;1,242,626.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;11,104,040 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;(22,875.05)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(161,770) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,063,339&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(57,077) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of September 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,985,601.68&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;22,064,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;17,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 90%; margin-top: 0; margin-bottom: 0; font: 8pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;The Trust did not hold any AVAX as of November 20, 2025 (Date of Seeding).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;D.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Avalanche&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;AVAX transactions are accounted for
on trade date. Realized gains and losses on the sale of AVAX are determined based on the average cost method. Under ASC Topic 946,
the average cost method is an accepted method to determine realized gains and losses on the sale of AVAX. Proceeds received by
the Trust from the issuance of baskets consist of AVAX or cash (used to purchase AVAX). Staking income is recognized on an accrual
basis. Deposits of AVAX will be held by Coinbase Custody Trust Company, LLC and/or Anchorage Digital Bank N.A. (collectively the
&#x201c;AVAX Custodians&#x201d;), on behalf of the Trust until (i) delivered out in connection with redemptions of baskets or cash
or (ii) sold by the Sponsor, which may be facilitated by the AVAX Custodians to pay fees due to the Sponsor and Trust expenses
and liabilities not assumed by the Sponsor or (iii) sold by the Sponsor to fund quarterly distributions to Shareholders from staking
rewards.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;E.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Staking&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Trust stakes a portion of the
Trust&#x2019;s AVAX through one or more staking services providers (the &#x201c;Staking Services Providers&#x201d;) to conduct such
staking activities. The Staking Services Providers will utilize the available&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;AVAX for staking by instructing the
AVAX Custodians to delegate such AVAX to a validator address selected in accordance with the Trust&#x2019;s Staking Policy. Any
staked AVAX will be inaccessible for approximately 16 days. While the Trust&#x2019;s assets are delegated to the Staking Services Providers
for staking activities, the Trust maintains all rights, title and interest to the staked AVAX; and as such, the staked assets are
reflected in Investments in AVAX, at fair value on the Statements of Assets and Liabilities. Staking rewards received in AVAX represent
non-cash consideration and are measured at fair value using the MarketVector&lt;sup&gt;TM&lt;/sup&gt; Avalanche Benchmark Rate used to calculate
the Trust&#x2019;s NAV on the date the income from staking rewards is recognized. The Sponsor has adopted a liquidity risk program
that provides a variety of mechanisms to monitor and manage the liquidity of the Trust&#x2019;s assets. Staking activity comes with
a risk of loss of AVAX. Coinbase Custody Trust Company, LLC was the only custodian holding staked AVAX during the period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;F.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Calculation of Net Asset Value&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Trust&#x2019;s net asset value
(&#x201c;NAV&#x201d;) is calculated based on the Trust&#x2019;s net asset holdings, as reconciled to the AVAX Custodians&#x2019; accounts,
on a market approach determined on a daily basis using the MarketVector&lt;sup&gt;TM&lt;/sup&gt; Avalanche Benchmark Rate price at 4:00 pm
EST. The Trust&#x2019;s NAV per Share is calculated by taking the current market value of its total assets, subtracting any liabilities,
and then dividing that total by the total number of outstanding Shares. The Trust Agreement gives the Sponsor the exclusive authority
to determine the Trust&#x2019;s NAV and the Trust&#x2019;s NAV per Share, which it has delegated to the administrator.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;G.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Distributions&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Staking consideration received by
the Trust from staking, net of staking fee, is intended to be distributed quarterly by the Trust. The amount of quarterly distributions
cannot be predicted with certainty. Distributions are paid in cash and they are not reinvested in additional shares of the Trust.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;H.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Federal Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
is treated as a grantor trust for federal income tax purposes and, therefore, no provision for federal income taxes is required.
Any staking income, expenses, gains and losses are passed through to the holders of Shares of the Trust. The Sponsor has reviewed
the tax positions for the period presented and has determined that no provision for income tax is required in the Trust&#x2019;s
financial statements&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;I.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Chief Financial Officer and Treasurer
of the Sponsor acts as the Trust&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), assessing performance and making
decisions about resource allocation. The CODM has determined that the Trust has a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;single&lt;/span&gt; operating segment based on the fact that
the Trust&#x2019;s long-term strategic asset allocation is pre-determined in accordance with the terms of its prospectus, with a
defined investment strategy which is executed by the Sponsor.&lt;span style="color: #03871A"&gt; &lt;/span&gt;The financial information provided
to and reviewed by the CODM is presented within the Trust&#x2019;s financial statements.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;J.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Interim Financial Statements&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The interim financial statements included
herein were prepared without audit according to the rules and regulations of the Securities and Exchange Commission. Certain information
and footnote disclosures normally included in financial statements prepared in accordance with GAAP may be omitted pursuant to
such rules and regulations. The financial statements reflect, in the opinion of management, all adjustments necessary that were
of a normal and recurring nature and adequate disclosures to present fairly the financial position and results of operations as
of and for the periods indicated. The results of operations for the three and nine months ended September 30, 2026, are not necessarily
indicative of the results to be expected for the full year or for any other period.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;These financial statements should
be read in conjunction with the audited financial statements and the notes thereto included in the Form 10-K previously filed with
the SEC.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c0" id="ixv-1417">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The preparation
of financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management
to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results
could differ from those estimates&lt;/span&gt;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
qualifies as an investment company solely for accounting purposes and not for any other purpose and follows accounting and reporting
requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt;
&lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and is not required to be registered, as an investment company
under the Investment Company Act of 1940, as amended&lt;/span&gt;.&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c0" id="ixv-1418">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;A.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Basis of Preparation and Use of Estimates&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The preparation
of financial statements in conformity with U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) requires management
to make estimates and assumptions that affect the reported amounts and disclosures in the financial statements. Actual results
could differ from those estimates&lt;/span&gt;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
qualifies as an investment company solely for accounting purposes and not for any other purpose and follows accounting and reporting
requirements of Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 946 Financial Services&#x2014;Investment Companies&lt;i&gt;
&lt;/i&gt;(&#x201c;ASC Topic 946&#x201d;)&lt;i&gt;, &lt;/i&gt;but is not registered, and is not required to be registered, as an investment company
under the Investment Company Act of 1940, as amended&lt;/span&gt;.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c0" id="ixv-1439">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;B.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Cash&lt;/i&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt; &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Cash, if any, represents cash deposits
held at a major financial institution and is subject to credit risk to the extent its balance exceeds the federally insured limits.&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c0" id="ixv-1452">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;C.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Investment Valuation&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
values its investment in AVAX and other assets and liabilities at fair value. Fair value is the price that would be received to
sell an asset or paid to transfer a liability in an orderly transaction between market participants on the measurement date&lt;/span&gt;.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
identifies and determines the AVAX principal market (or in the absence of a principal market, the
most advantageous market) for GAAP financial statement purposes consistent with the application of fair value measurement framework
in Financial Accounting Standards Board (&#x201c;FASB&#x201d;) ASC 820 at 11:59 p.m. EST. Under ASC 820, a principal market is the
market with the greatest volume and activity level for the asset or liability. The Sponsor on behalf of the Trust will determine
in its sole discretion the valuation sources and policies used to prepare the Trust&#x2019;s financial statements in accordance
with GAAP.&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Various
inputs are used in determining the fair value of assets and liabilities. Inputs may be based on independent market data or they
may be internally developed. These inputs are categorized into a disclosure hierarchy consisting of three broad levels for financial
reporting purposes. The three levels of the fair value hierarchy are as follows&lt;/span&gt;:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;Level 1 &#x2013;
Unadjusted quoted prices in active markets for identical assets or liabilities&lt;/span&gt;;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Level
2 &#x2013; Inputs other than quoted prices included within Level 1 that are observable for the asset or liability either directly
or indirectly, including quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar
assets or liabilities in markets that are not considered to be active, inputs other than quoted prices that are observable for
the asset or liability, and inputs that are derived principally from or corroborated by observable market data by correlation or
other means; and&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Level 3 &#x2013; Unobservable inputs
where there are little or no market activity for the asset or liability, including the Trust&#x2019;s assumptions used in determining
the fair value of investments.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following is
a summary of the fair value hierarchy as of September 30, 2026 and December 31, 2025&lt;/span&gt;:&lt;/p&gt;&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;September 30, 2026&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment
    in AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment in
    AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following represents
the changes in quantity of AVAX and the respective fair value&lt;/span&gt;:&lt;/p&gt;&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of January 1, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;559,830.28 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,598,904 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;1,242,626.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;11,104,040 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;(22,875.05)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(161,770) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,063,339&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(57,077) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of September 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,985,601.68&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;22,064,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;17,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;table cellpadding="0" style="width: 90%; margin-top: 0; margin-bottom: 0; font: 8pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;The Trust did not hold any AVAX as of November 20, 2025 (Date of Seeding).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c0" id="ixv-1510">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following is
a summary of the fair value hierarchy as of September 30, 2026 and December 31, 2025&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: bold 8pt Times New Roman, Times, Serif; margin: 0 0 0 29.6pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left; padding-bottom: 1px"&gt;September 30, 2026&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 1&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 2&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Level 3&lt;/td&gt;&lt;td style="font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="font-weight: bold; text-align: center; border-bottom: Black 1px solid"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="width: 40%; font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment
    in AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 3%; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="width: 10%; text-align: right; border-bottom: Black 3px double"&gt;22,064,999&lt;/td&gt;&lt;td style="width: 1%; text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;December 31, 2025&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 1&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 2&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Level 3&lt;/td&gt;&lt;td style="text-align: center; font-weight: bold; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1px solid; font-weight: bold; text-align: center"&gt;Total&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;Assets&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="font-size: 10pt; text-align: left; padding-bottom: 3px; padding-left: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Investment in
    AVAX&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&#160;&#160;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;&#x2014;&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;td style="border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;2,517,563&lt;/td&gt;&lt;td style="text-align: left; border-bottom: Black 3px double"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CryptoAssetFairValue contextRef="c8" decimals="0" id="ixv-3759" unitRef="usd">22064999</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c9" decimals="0" id="ixv-3760" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c10" decimals="0" id="ixv-3761" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c2" decimals="0" id="ixv-3762" unitRef="usd">22064999</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c11" decimals="0" id="ixv-3763" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c12" decimals="0" id="ixv-3764" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c13" decimals="0" id="ixv-3765" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <us-gaap:CryptoAssetFairValue contextRef="c3" decimals="0" id="ixv-3766" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <vavx:ChangesInQuantityOfAVAXAndRespectiveFairValueTableTextBlock contextRef="c0" id="ixv-1630">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&lt;span style="font-size: 10pt"&gt;The following represents
the changes in quantity of AVAX and the respective fair value&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of January 1, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;559,830.28 &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;5,598,904 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;1,242,626.55&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;11,104,040 &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#160;(22,875.05)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(161,770) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold in-kind&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&#160;&#160;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#160;&lt;/p&gt; &lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 0 7.2pt; text-align: right; text-indent: -7.2pt"&gt;&#x2014;&lt;/p&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;3,063,339&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: top; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;(57,077) &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of September 30, 2026&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;1,985,601.68&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;22,064,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 80%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-left: 36pt; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1pt solid; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;AVAX&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 8pt"&gt;&lt;b&gt;Fair Value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; width: 58%; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Beginning balance as of November 20, 2025&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 2%; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left; width: 2%"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right; width: 18%"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX purchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,500,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;AVAX sold&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-left: 10pt; text-indent: -10pt"&gt;&lt;span style="font-size: 10pt"&gt;Net change in unrealized appreciation (depreciation) from investment in&#160;AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;17,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&lt;span style="font-size: 10pt"&gt;Net realized gain (loss) on investment in AVAX&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1px solid; vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 3px"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;&lt;b&gt;Ending balance as of December 31, 2025&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;206,019.90&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; vertical-align: bottom; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;&lt;span style="font-size: 8pt"&gt;2,517,563&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 36pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="width: 90%; margin-top: 0; margin-bottom: 0; font: 8pt Times New Roman, Times, Serif; margin-left: 36pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td&gt;The Trust did not hold any AVAX as of November 20, 2025 (Date of Seeding).&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</vavx:ChangesInQuantityOfAVAXAndRespectiveFairValueTableTextBlock>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c14"
      decimals="INF"
      id="ixv-3767"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c15" decimals="0" id="ixv-3768" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <vavx:CryptoAssetNumberOfUnitsPurchased
      contextRef="c16"
      decimals="INF"
      id="ixv-3769"
      unitRef="Avalanche">559830.28</vavx:CryptoAssetNumberOfUnitsPurchased>
    <us-gaap:CryptoAssetPurchase contextRef="c17" decimals="0" id="ixv-3770" unitRef="usd">5598904</us-gaap:CryptoAssetPurchase>
    <vavx:CryptoAssetNumberOfUnitsPurchasedInKind
      contextRef="c16"
      decimals="INF"
      id="ixv-3771"
      unitRef="Avalanche">1242626.55</vavx:CryptoAssetNumberOfUnitsPurchasedInKind>
    <vavx:CryptoAssetPurchaseInKind contextRef="c17" decimals="0" id="ixv-3772" unitRef="usd">11104040</vavx:CryptoAssetPurchaseInKind>
    <vavx:CryptoAssetNumberOfUnitsSold
      contextRef="c16"
      decimals="INF"
      id="ixv-3773"
      unitRef="Avalanche">22875.05</vavx:CryptoAssetNumberOfUnitsSold>
    <us-gaap:CryptoAssetSale contextRef="c17" decimals="0" id="ixv-3774" unitRef="usd">161770</us-gaap:CryptoAssetSale>
    <vavx:CryptoAssetNumberOfUnitsSoldInKind
      contextRef="c16"
      decimals="INF"
      id="ixv-3775"
      unitRef="Avalanche">0</vavx:CryptoAssetNumberOfUnitsSoldInKind>
    <vavx:CryptoAssetSaleInKind contextRef="c17" decimals="0" id="ixv-3776" unitRef="usd">0</vavx:CryptoAssetSaleInKind>
    <vavx:NetUnrealizedAppreciationOnInvestmentInAVAXShares
      contextRef="c16"
      decimals="0"
      id="ixv-3777"
      unitRef="shares">0</vavx:NetUnrealizedAppreciationOnInvestmentInAVAXShares>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c17" decimals="0" id="ixv-3778" unitRef="usd">3063339</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <vavx:NetRealizedLossOnInvestmentInAVAXShares
      contextRef="c16"
      decimals="0"
      id="ixv-3779"
      unitRef="shares">0</vavx:NetRealizedLossOnInvestmentInAVAXShares>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c17" decimals="0" id="ixv-3780" unitRef="usd">-57077</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c18"
      decimals="INF"
      id="ixv-3781"
      unitRef="Avalanche">1985601.68</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c19" decimals="0" id="ixv-3782" unitRef="usd">22064999</us-gaap:CryptoAssetFairValue>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c20"
      decimals="INF"
      id="ix_49_fact"
      unitRef="Avalanche">0</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c21" decimals="0" id="ix_50_fact" unitRef="usd">0</us-gaap:CryptoAssetFairValue>
    <vavx:CryptoAssetNumberOfUnitsPurchased
      contextRef="c22"
      decimals="INF"
      id="ixv-3785"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsPurchased>
    <us-gaap:CryptoAssetPurchase contextRef="c23" decimals="0" id="ixv-3786" unitRef="usd">2500000</us-gaap:CryptoAssetPurchase>
    <vavx:CryptoAssetNumberOfUnitsSold
      contextRef="c22"
      decimals="INF"
      id="ixv-3787"
      unitRef="Avalanche">0</vavx:CryptoAssetNumberOfUnitsSold>
    <us-gaap:CryptoAssetSale contextRef="c23" decimals="0" id="ixv-3788" unitRef="usd">0</us-gaap:CryptoAssetSale>
    <vavx:NetUnrealizedAppreciationOnInvestmentInAVAXShares
      contextRef="c22"
      decimals="0"
      id="ixv-3789"
      unitRef="shares">0</vavx:NetUnrealizedAppreciationOnInvestmentInAVAXShares>
    <us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating contextRef="c23" decimals="0" id="ixv-3790" unitRef="usd">17563</us-gaap:CryptoAssetUnrealizedGainLossOperatingAndNonoperating>
    <vavx:NetRealizedLossOnInvestmentInAVAXShares
      contextRef="c22"
      decimals="0"
      id="ixv-3791"
      unitRef="shares">0</vavx:NetRealizedLossOnInvestmentInAVAXShares>
    <us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating contextRef="c23" decimals="0" id="ixv-3792" unitRef="usd">0</us-gaap:CryptoAssetRealizedGainLossOperatingAndNonoperating>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c14"
      decimals="INF"
      id="ixv-3793"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:CryptoAssetFairValue contextRef="c15" decimals="0" id="ixv-3794" unitRef="usd">2517563</us-gaap:CryptoAssetFairValue>
    <vavx:YearOfInception contextRef="c0" id="ixv-3796">2025</vavx:YearOfInception>
    <vavx:AvalanchePolicyTextBlock contextRef="c0" id="ixv-1820">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;D.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Avalanche&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;AVAX transactions are accounted for
on trade date. Realized gains and losses on the sale of AVAX are determined based on the average cost method. Under ASC Topic 946,
the average cost method is an accepted method to determine realized gains and losses on the sale of AVAX. Proceeds received by
the Trust from the issuance of baskets consist of AVAX or cash (used to purchase AVAX). Staking income is recognized on an accrual
basis. Deposits of AVAX will be held by Coinbase Custody Trust Company, LLC and/or Anchorage Digital Bank N.A. (collectively the
&#x201c;AVAX Custodians&#x201d;), on behalf of the Trust until (i) delivered out in connection with redemptions of baskets or cash
or (ii) sold by the Sponsor, which may be facilitated by the AVAX Custodians to pay fees due to the Sponsor and Trust expenses
and liabilities not assumed by the Sponsor or (iii) sold by the Sponsor to fund quarterly distributions to Shareholders from staking
rewards.&lt;/p&gt;</vavx:AvalanchePolicyTextBlock>
    <vavx:StakingPolicyTextBlock contextRef="c0" id="ixv-1832">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;E.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Staking&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Trust stakes a portion of the
Trust&#x2019;s AVAX through one or more staking services providers (the &#x201c;Staking Services Providers&#x201d;) to conduct such
staking activities. The Staking Services Providers will utilize the available&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;AVAX for staking by instructing the
AVAX Custodians to delegate such AVAX to a validator address selected in accordance with the Trust&#x2019;s Staking Policy. Any
staked AVAX will be inaccessible for approximately 16 days. While the Trust&#x2019;s assets are delegated to the Staking Services Providers
for staking activities, the Trust maintains all rights, title and interest to the staked AVAX; and as such, the staked assets are
reflected in Investments in AVAX, at fair value on the Statements of Assets and Liabilities. Staking rewards received in AVAX represent
non-cash consideration and are measured at fair value using the MarketVector&lt;sup&gt;TM&lt;/sup&gt; Avalanche Benchmark Rate used to calculate
the Trust&#x2019;s NAV on the date the income from staking rewards is recognized. The Sponsor has adopted a liquidity risk program
that provides a variety of mechanisms to monitor and manage the liquidity of the Trust&#x2019;s assets. Staking activity comes with
a risk of loss of AVAX. Coinbase Custody Trust Company, LLC was the only custodian holding staked AVAX during the period.&lt;/p&gt;</vavx:StakingPolicyTextBlock>
    <vavx:StakedDigitalAssetInaccessibilityPeriod contextRef="c0" id="ixv-3797">P16D</vavx:StakedDigitalAssetInaccessibilityPeriod>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c0" id="ixv-1872">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;F.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Calculation of Net Asset Value&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Trust&#x2019;s net asset value
(&#x201c;NAV&#x201d;) is calculated based on the Trust&#x2019;s net asset holdings, as reconciled to the AVAX Custodians&#x2019; accounts,
on a market approach determined on a daily basis using the MarketVector&lt;sup&gt;TM&lt;/sup&gt; Avalanche Benchmark Rate price at 4:00 pm
EST. The Trust&#x2019;s NAV per Share is calculated by taking the current market value of its total assets, subtracting any liabilities,
and then dividing that total by the total number of outstanding Shares. The Trust Agreement gives the Sponsor the exclusive authority
to determine the Trust&#x2019;s NAV and the Trust&#x2019;s NAV per Share, which it has delegated to the administrator.&lt;/p&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:InvestmentCompanyDistributionPolicyTextBlock contextRef="c0" id="ixv-1885">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;G.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Distributions&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;Staking consideration received by
the Trust from staking, net of staking fee, is intended to be distributed quarterly by the Trust. The amount of quarterly distributions
cannot be predicted with certainty. Distributions are paid in cash and they are not reinvested in additional shares of the Trust.&lt;/p&gt;</us-gaap:InvestmentCompanyDistributionPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c0" id="ixv-1897">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;H.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Federal Income Taxes&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust
is treated as a grantor trust for federal income tax purposes and, therefore, no provision for federal income taxes is required.
Any staking income, expenses, gains and losses are passed through to the holders of Shares of the Trust. The Sponsor has reviewed
the tax positions for the period presented and has determined that no provision for income tax is required in the Trust&#x2019;s
financial statements&lt;/span&gt;.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c0" id="ixv-1910">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;I.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Segment Reporting&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The Chief Financial Officer and Treasurer
of the Sponsor acts as the Trust&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), assessing performance and making
decisions about resource allocation. The CODM has determined that the Trust has a &lt;span style="-sec-ix-hidden: hidden-fact-2"&gt;single&lt;/span&gt; operating segment based on the fact that
the Trust&#x2019;s long-term strategic asset allocation is pre-determined in accordance with the terms of its prospectus, with a
defined investment strategy which is executed by the Sponsor.&lt;span style="color: #03871A"&gt; &lt;/span&gt;The financial information provided
to and reviewed by the CODM is presented within the Trust&#x2019;s financial statements.&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <vavx:InterimFinancialStatementsPolicyTextBlock contextRef="c0" id="ixv-1924">&lt;table cellpadding="0" style="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: top"&gt; &lt;td style="width: 36pt; font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif"&gt;J.&lt;/span&gt;&lt;/td&gt; &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;i&gt;Interim Financial Statements&lt;/i&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;The interim financial statements included
herein were prepared without audit according to the rules and regulations of the Securities and Exchange Commission. Certain information
and footnote disclosures normally included in financial statements prepared in accordance with GAAP may be omitted pursuant to
such rules and regulations. The financial statements reflect, in the opinion of management, all adjustments necessary that were
of a normal and recurring nature and adequate disclosures to present fairly the financial position and results of operations as
of and for the periods indicated. The results of operations for the three and nine months ended September 30, 2026, are not necessarily
indicative of the results to be expected for the full year or for any other period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 36pt; text-align: justify"&gt;These financial statements should
be read in conjunction with the audited financial statements and the notes thereto included in the Form 10-K previously filed with
the SEC.&lt;/p&gt;</vavx:InterimFinancialStatementsPolicyTextBlock>
    <vavx:TrustExpensesandOtherAgreementsTextBlock contextRef="c0" id="ixv-1962">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 3. Trust Expenses and Other Agreements&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Trust pays the Sponsor a unified fee (the
&#x201c;Sponsor Fee&#x201d;) of 0.20% on average daily net assets, that accrues daily and pays monthly. The Sponsor agreed to waive
that fee for the first $500 million in net assets up until February 28, 2026. The Sponsor has agreed to pay all operating expenses
(except for extraordinary expenses, including but not limited to, non-recurring expenses and costs of services performed by the
Sponsor or a service provider on behalf of the Trust to protect the Trust or the interests of Shareholders, such as the Custodian
Staking Facilitation Fee, and in connection with any indemnification of agents, service providers or counterparties of the Trust
and extraordinary legal fees and expenses, including any legal fees and expenses incurred in connection with litigation, regulatory
enforcement or investigation matters) out of the Sponsor Fee. Coinbase Crypto Services currently serves as the Staking Service
Provider for the Trust and is entitled to a staking fee of 4% of the staking income earned by the Trust&#x2019;s staked assets as
presented in the Statements of Operations. The Sponsor from time to time will sell AVAX, which may be facilitated by one or more
liquidity providers and/or the AVAX Custodians or an affiliate thereof, in such quantity as is necessary to permit payment of the
Sponsor Fee and Trust expenses and liabilities not assumed by the Sponsor.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Trustee fee is paid by the Sponsor and
is not an expense of the Trust.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust may
hold its AVAX at either of the AVAX Custodians, both of which are regulated third-party custodians that carry insurance and are
responsible for safekeeping of AVAX owned by the Trust and holding private keys that provide access to the AVAX in the Trust&#x2019;s
AVAX account.&lt;/span&gt;&lt;span style="font-size: 12pt; color: #DB3326"&gt; &lt;/span&gt;&lt;span style="font-size: 10pt"&gt;As of September 30, 2026
the Trust held all of its AVAX at Coinbase Custody Trust Company, LLC.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;State Street Bank and Trust Company
serves as the Trust&#x2019;s administrator, transfer agent and cash custodian&lt;/span&gt;.&lt;/p&gt;</vavx:TrustExpensesandOtherAgreementsTextBlock>
    <vavx:SponsorFeeAtMonthlyRateOfAverageDailyNetAssets contextRef="c0" decimals="4" id="ixv-3798" unitRef="pure">0.002</vavx:SponsorFeeAtMonthlyRateOfAverageDailyNetAssets>
    <us-gaap:SponsorFees contextRef="c24" decimals="-6" id="ixv-3799" unitRef="usd">500000000</us-gaap:SponsorFees>
    <vavx:SponsorFeeAtAnnualRateOfNetAssets contextRef="c0" decimals="2" id="ixv-3800" unitRef="pure">0.04</vavx:SponsorFeeAtAnnualRateOfNetAssets>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="c0" id="ixv-1980">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 4. Related Parties&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;The Sponsor is considered to be a related
party to the Trust&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;MarketVector Indexes
GmbH is the index sponsor and index administrator for the MarketVector&lt;sup&gt;TM&lt;/sup&gt; Avalanche Benchmark Rate, which is used by
the Trust to determine its NAV. MarketVector Indexes GmbH is an indirectly wholly-owned subsidiary of VanEck&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;Van Eck Securities Corporation, a marketing
agent to the Trust, is a wholly-owned subsidiary of VanEck&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VanEck was the initial seed investor (&#x201c;Seed
Capital Investor&#x201d;) and purchased for cash 4,000 Shares (the &#x201c;Seed Shares&#x201d;) at a per-Share price of $25.00 on
November 20, 2025. Total proceeds to the Trust from the sale of the Seed Shares were $100,000. On December 22 2025, the Seed Shares
were redeemed for cash and the Seed Capital Investor purchased the &#x201c;Seed Creation Baskets&#x201d;, comprising a total of 100,000
Shares at a per-Share price of $25.00. Total proceeds to the Trust from the sale of the Seed Creation Baskets were $2,500,000 which
resulted in the Trust receiving 206,019.90 AVAX. As of September 30, 2026 and December 31, 2025, the Seed Capital Investor&#x2019;s ownership
in the Trust represents approximately 11% and 100% of net assets, respectively.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;VanEck is a minority equity holder in Metatech
Holdings, the parent company of Nonco LLC and holds approximately 5% of its equity. Nonco LLC is a liquidity provider to the Trust,
and the Trust conducts its AVAX purchase and sale transactions by trading directly with liquidity providers, including Nonco LLC.
During the nine months ended September 30, 2026, the Trust had the following purchase and sale transactions through Nonco LLC:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px; font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quantity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; font-size: 10pt; text-align: center; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Cost/Proceeds&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-indent: 0pt; font-size: 10pt; width: 71%"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;Purchase&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;207,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: left; text-indent: -7.2pt; font-size: 10pt; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;2,303,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-indent: 0pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Sale&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;20,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;139,984&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c25"
      decimals="INF"
      id="ixv-3801"
      unitRef="shares">4000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c26"
      decimals="INF"
      id="ixv-3802"
      unitRef="usdPershares">25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c25" decimals="0" id="ixv-3803" unitRef="usd">100000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:SharesIssued
      contextRef="c27"
      decimals="INF"
      id="ixv-3804"
      unitRef="shares">100000</us-gaap:SharesIssued>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="c27"
      decimals="INF"
      id="ixv-3805"
      unitRef="usdPershares">25</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c28" decimals="0" id="ixv-3806" unitRef="usd">2500000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <vavx:CryptoAssetNumberOfUnitsHeld
      contextRef="c27"
      decimals="INF"
      id="ixv-3807"
      unitRef="Avalanche">206019.9</vavx:CryptoAssetNumberOfUnitsHeld>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c29"
      decimals="INF"
      id="ixv-3808"
      unitRef="pure">0.11</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:InvestmentOwnedPercentOfNetAssets
      contextRef="c30"
      decimals="INF"
      id="ixv-3809"
      unitRef="pure">1</us-gaap:InvestmentOwnedPercentOfNetAssets>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="c31"
      decimals="INF"
      id="ixv-3810"
      unitRef="pure">0.05</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock contextRef="c0" id="ixv-3811">During the nine months ended September 30, 2026, the Trust had the following purchase and sale transactions through Nonco LLC:&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 40%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; font-size: 10pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px; font-size: 10pt; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; font-size: 10pt; text-align: center"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Quantity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; font-size: 10pt; text-align: center; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; font-size: 10pt; text-align: center; border-bottom: Black 1px solid"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Cost/Proceeds&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-indent: 0pt; font-size: 10pt; width: 71%"&gt;&lt;span style="font-size: 10pt; font-style: normal"&gt;Purchase&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;207,609&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 4%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: left; text-indent: -7.2pt; font-size: 10pt; width: 1%"&gt;&lt;span style="font-size: 10pt"&gt;$&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt; width: 10%"&gt;&lt;span style="font-size: 10pt"&gt;2,303,442&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; text-indent: 0pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;Sale&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;20,080&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-left: 7.2pt; text-align: right; text-indent: -7.2pt; font-size: 10pt"&gt;&lt;span style="font-size: 10pt"&gt;139,984&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:ScheduleOfRelatedPartyTransactionsTableTextBlock>
    <vavx:CryptoAssetNumberOfUnitsPurchased
      contextRef="c32"
      decimals="INF"
      id="ixv-3812"
      unitRef="Avalanche">207609</vavx:CryptoAssetNumberOfUnitsPurchased>
    <us-gaap:PaymentForAcquisitionCryptoAsset contextRef="c33" decimals="0" id="ixv-3813" unitRef="usd">2303442</us-gaap:PaymentForAcquisitionCryptoAsset>
    <vavx:CryptoAssetNumberOfUnitsSold
      contextRef="c32"
      decimals="INF"
      id="ixv-3814"
      unitRef="Avalanche">20080</vavx:CryptoAssetNumberOfUnitsSold>
    <us-gaap:ProceedsFromDisposalCryptoAsset contextRef="c33" decimals="0" id="ixv-3815" unitRef="usd">139984</us-gaap:ProceedsFromDisposalCryptoAsset>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="c0" id="ixv-2056">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 5. Capital Share Transactions&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Investors can buy and sell Shares of the Trust
in secondary market transactions through brokers. Shares trade on the Exchange under the ticker symbol VAVX. Shares are bought
and sold throughout the trading day like other publicly traded securities.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;The Trust continuously offers the Trust Shares
in baskets consisting of 25,000 Shares to authorized participants. Authorized participants pay a transaction fee for each order
they place to create or redeem one or more baskets. The administrator calculates the cost to purchase (or sell in the case of a
redemption order) the amount of AVAX represented by the baskets being created (or redeemed); the amount of AVAX represented is
equal to the combined NAV of the number of Shares included in the baskets being created (or redeemed).&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Trust creates
and redeems Shares, but only in one or more baskets. Baskets are only made in exchange for delivery to the Trust or the distribution
by the Trust of the amount of AVAX represented by the baskets being created or redeemed, the amount of which is equal to the combined
NAV of the number of Shares included in the baskets being created or redeemed determined as of 4:00 p.m. EST on the day the order
to create or redeem baskets is properly received. The authorized participants deliver cash or AVAX to create baskets and receive
cash or AVAX when redeeming Shares. For a subscription in cash, an authorized participant will deliver cash to the Trust&#x2019;s
account at the cash custodian, which the Sponsor will then use to purchase AVAX from a liquidity provider chosen by the Sponsor.
For a redemption in cash, the Sponsor will arrange for the AVAX represented by the basket to be sold to a liquidity provider chosen
by the Sponsor and the cash proceeds distributed from the Trust&#x2019;s account at the cash custodian to the authorized participant.
For an &#x201c;in-kind&#x201d; subscription, authorized participants will deliver, or arrange for the delivery by the authorized
participant&#x2019;s designee of, AVAX to the Trust&#x2019;s account with the AVAX Custodians in exchange for Shares when they purchase
Shares. For an &#x201c;in-kind&#x201d; redemption transaction with the Trust, when authorized participants redeem Shares, the Trust
through the AVAX Custodians, will deliver AVAX to such authorized participants, or a designee thereof, in exchange for their Shares.
Only authorized participants may place orders to create and redeem baskets through the transfer agent. The transfer agent will
coordinate with the Trust&#x2019;s AVAX Custodians to facilitate settlement of the Shares and AVAX&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;Share and capital activity is as follows&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Three Months Ended&lt;br/&gt;
    September 30, 2026&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="vertical-align: top; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Nine Months Ended&lt;br/&gt;
    September 30, 2026&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; width: 25%"&gt;&lt;span style="font-style: normal"&gt;Beginning
    of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;825,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;16,359,354&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;100,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;2,500,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;Shares issued&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;125,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;2,505,622&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;850,000&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;16,364,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;Shares redeemed&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&lt;span style="font-style: normal"&gt;End
    of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;950,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;18,864,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;950,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;18,864,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td style="text-align: justify"&gt;No comparative share activity have been provided as the Trust did not have any operations
as of September 30, 2025.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="c34"
      decimals="INF"
      id="ixv-3816"
      unitRef="shares">25000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ScheduleOfStockholdersEquityTableTextBlock contextRef="c0" id="ixv-2067">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;Share and capital activity is as follows&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="vertical-align: top; border-bottom: Black 1pt solid; text-align: center"&gt;&lt;b&gt;Three Months Ended&lt;br/&gt;
    September 30, 2026&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="4" style="vertical-align: top; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Nine Months Ended&lt;br/&gt;
    September 30, 2026&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: center"&gt;&lt;b&gt;Shares&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: bottom; text-align: center; border-bottom: Black 1px solid"&gt;&lt;b&gt;Amount&lt;/b&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; width: 25%"&gt;&lt;span style="font-style: normal"&gt;Beginning
    of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;825,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;16,359,354&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;100,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left; width: 1%"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; width: 8%"&gt;2,500,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; width: 1%"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom"&gt;Shares issued&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;125,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;2,505,622&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;850,000&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;16,364,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="background-color: rgb(229,255,255)"&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 1px"&gt;Shares redeemed&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: left"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 1px solid; text-align: right"&gt;&#x2014;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-bottom: 3px"&gt;&lt;span style="font-style: normal"&gt;End
    of period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;950,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 3px double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;18,864,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;950,000&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: left"&gt;$&lt;/td&gt;
    &lt;td style="vertical-align: bottom; border-bottom: Black 3px double; text-align: right"&gt;18,864,976&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; border-spacing: 0px;"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 18pt; text-align: left"&gt;(a)&lt;/td&gt;&lt;td style="text-align: justify"&gt;No comparative share activity have been provided as the Trust did not have any operations
as of September 30, 2025.&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityTableTextBlock>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c6"
      decimals="INF"
      id="ix_51_fact"
      unitRef="shares">825000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c6" decimals="0" id="ix_52_fact" unitRef="usd">16359354</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c3"
      decimals="INF"
      id="ix_53_fact"
      unitRef="shares">100000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c3" decimals="0" id="ix_54_fact" unitRef="usd">2500000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c5"
      decimals="INF"
      id="ix_55_fact"
      unitRef="shares">125000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c5" decimals="0" id="ix_56_fact" unitRef="usd">2505622</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="c0"
      decimals="INF"
      id="ix_57_fact"
      unitRef="shares">850000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c0" decimals="0" id="ix_58_fact" unitRef="usd">16364976</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c5"
      decimals="INF"
      id="ix_59_fact"
      unitRef="shares">0</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c5" decimals="0" id="ix_60_fact" unitRef="usd">0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:StockRedeemedOrCalledDuringPeriodShares
      contextRef="c0"
      decimals="INF"
      id="ix_61_fact"
      unitRef="shares">0</us-gaap:StockRedeemedOrCalledDuringPeriodShares>
    <us-gaap:StockRedeemedOrCalledDuringPeriodValue contextRef="c0" decimals="0" id="ix_62_fact" unitRef="usd">0</us-gaap:StockRedeemedOrCalledDuringPeriodValue>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ix_63_fact"
      unitRef="shares">950000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c2" decimals="0" id="ix_64_fact" unitRef="usd">18864976</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="c2"
      decimals="INF"
      id="ix_65_fact"
      unitRef="shares">950000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c2" decimals="0" id="ix_66_fact" unitRef="usd">18864976</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c0" id="ixv-2163">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-size: 10pt"&gt;&lt;b&gt;Note 6. Commitments and Contingent&lt;/b&gt;&lt;/span&gt;&lt;b&gt;
&lt;span style="font-size: 10pt"&gt;Liabilities&lt;/span&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;In the normal
course of business, the Trust enters into contracts that contain a variety of general indemnifications. The Trust&#x2019;s maximum
exposure under these agreements is unknown as this would involve future claims that may be made against the Trust that have not
yet occurred. However, the Sponsor believes the risk of loss under these arrangements to be remote&lt;/span&gt;.&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskDisclosureTextBlock contextRef="c0" id="ixv-2176">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 7. Risk&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;Substantially all of the Trust&#x2019;s assets
are holdings of AVAX, which creates a concentration risk associated with fluctuations in the value of AVAX due to a number of factors.
Accordingly, a decline in the value of AVAX will have an adverse effect on the value of the Shares of the Trust. Factors that may
have the effect of causing a decline in the value of AVAX include high volatility, which could have a negative impact on the performance
of the Trust. AVAX platforms are relatively new and may be unregulated or may be subject to regulation in a relevant jurisdiction,
but may not be complying, and therefore, may be more exposed to fraud and security breaches than established, regulated exchanges
for other financial assets or instruments, which could have a negative impact on the performance of the Trust. The value of&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;the Shares depends on the development and acceptance
of the AVAX network. The slowing or stopping of the development or acceptance of the AVAX network may adversely affect an investment
in the Trust. The price of AVAX on the AVAX market has exhibited periods of extreme volatility. Digital assets such as AVAX were
only introduced within the past decade, and the medium-to-long term value of the Shares is subject to a number of factors relating
to the capabilities and development of block-chain technologies and to the fundamental investment characteristics of digital assets
that are uncertain and difficult to evaluate. The Trust is subject to risks due to its concentration of investments in a single
asset class. Possible illiquid markets may exacerbate losses or increase the variability between the Trust&#x2019;s NAV and its
market price. The amount of AVAX represented by the Shares may decline over time.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Future and current
regulations by a United States or foreign government or quasi-governmental agency could have an adverse effect on an investment
in the Trust. Shareholders do not have the protections associated with ownership of Shares in an investment company registered
under the 1940 Act or the protections afforded by the Commodity Exchange Act. Future legal or regulatory developments may negatively
affect the value of AVAX or require the Trust or the Sponsor to become registered with the SEC or CFTC, which may cause the Trust
to liquidate&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The Exchange on
which the Shares are listed may halt trading in the Trust&#x2019;s Shares, which would adversely impact a Shareholder&#x2019;s ability
to sell Shares. The market infrastructure of the AVAX spot market could result in the absence of active authorized participants
able to support the trading activity of the Trust&lt;/span&gt;.&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;Shareholders that
are not authorized participants may only purchase or sell their Shares in secondary trading markets, and the conditions associated
with trading in secondary markets may adversely affect Shareholders&#x2019; investment in the Shares&lt;/span&gt;.&lt;/p&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:InvestmentCompanyFinancialHighlightsTextBlock contextRef="c0" id="ixv-2240">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 8. Financial Highlights&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The financial
highlights summarize certain per share operating information and financial ratios of net investment income and expenses, to daily
average net assets for the periods below. An individual investor&#x2019;s return and ratios may vary based on the timing of capital transactions&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; white-space: nowrap;"&gt;Three Months&lt;br/&gt;
 Ended&lt;br/&gt;
September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; white-space: nowrap;"&gt;Nine Months&lt;br/&gt;
 Ended&lt;br/&gt;
September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1px solid"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1px solid"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="width: 66%"&gt;Net asset value per share, beginning of period&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;14.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;From investment operations:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net investment income&lt;sup&gt;(b)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;Net realized gain (loss) and change in unrealized appreciation
    (depreciation) from investments in avalanche&lt;sup&gt;(c)&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;9.21&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(2.27)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt; padding-bottom: 1px"&gt;Net increase (decrease) resulting from operations&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;9.37&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(1.79)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 20pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Less distribution to shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;Decrease in net assets resulting from distributions to shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(0.17)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(0.17)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt; padding-bottom: 3px"&gt;Net asset value per share, end of period&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;23.22&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;23.22&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Total return&lt;sup&gt;(d)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67.77%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.60)%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Ratios to average net assets&lt;sup&gt;(e)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Gross expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.18%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net investment income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.23%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.76%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; width: 18pt; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;No prior comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Net investment income per share has been calculated based upon an average of daily shares outstanding.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;The amount shown for a share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s shares in relation to fluctuating market values of AVAX.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Returns are not annualized and include adjustments required by GAAP. Returns for financial statements purposes may differ from net asset values and performance reported elsewhere by the Trust.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Annualized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTextBlock>
    <us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock contextRef="c0" id="ixv-2245">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-size: 10pt"&gt;The financial
highlights summarize certain per share operating information and financial ratios of net investment income and expenses, to daily
average net assets for the periods below. An individual investor&#x2019;s return and ratios may vary based on the timing of capital transactions&lt;/span&gt;:&lt;/p&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; white-space: nowrap;"&gt;Three Months&lt;br/&gt;
 Ended&lt;br/&gt;
September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; white-space: nowrap;"&gt;Nine Months&lt;br/&gt;
 Ended&lt;br/&gt;
September 30,&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1px solid"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: center; border-bottom: Black 1px solid"&gt;2026&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="width: 66%"&gt;Net asset value per share, beginning of period&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;14.02&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 3%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;25.18&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;From investment operations:&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net investment income&lt;sup&gt;(b)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.16&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.48&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;Net realized gain (loss) and change in unrealized appreciation
    (depreciation) from investments in avalanche&lt;sup&gt;(c)&lt;/sup&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;9.21&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(2.27)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 20pt; padding-bottom: 1px"&gt;Net increase (decrease) resulting from operations&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;9.37&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(1.79)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 20pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Less distribution to shareholders&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;Decrease in net assets resulting from distributions to shareholders&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(0.17)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 1px solid"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 1px solid"&gt;(0.17)&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 10pt; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 1px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="padding-left: 0pt; padding-bottom: 3px"&gt;Net asset value per share, end of period&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;23.22&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 3px"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left; border-bottom: Black 3px double"&gt;$&lt;/td&gt;&lt;td style="text-align: right; border-bottom: Black 3px double"&gt;23.22&lt;/td&gt;&lt;td style="text-align: left; padding-bottom: 3px"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Total return&lt;sup&gt;(d)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;67.77%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;(6.60)%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left"&gt;Ratios to average net assets&lt;sup&gt;(e)&lt;/sup&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Gross expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; "&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net expense&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.20%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;0.18%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(229,255,255)"&gt;
    &lt;td style="text-align: left; padding-left: 10pt"&gt;Net investment income&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;4.23%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;3.76%&lt;/td&gt;&lt;td style="text-align: left"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" style="font: 8pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; width: 18pt; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;No prior comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Net investment income per share has been calculated based upon an average of daily shares outstanding.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;The amount shown for a share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s shares in relation to fluctuating market values of AVAX.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Returns are not annualized and include adjustments required by GAAP. Returns for financial statements purposes may differ from net asset values and performance reported elsewhere by the Trust.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt; &lt;td style="text-align: left; font-family: Times New Roman, Times, Serif; vertical-align: top"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt; &lt;td style="font-family: Times New Roman, Times, Serif"&gt;&lt;span style="font: 8pt Times New Roman, Times, Serif"&gt;Annualized.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</us-gaap:InvestmentCompanyFinancialHighlightsTableTextBlock>
    <us-gaap:NetAssetValuePerShare
      contextRef="c6"
      decimals="2"
      id="ix_67_fact"
      unitRef="usdPershares">14.02</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c3"
      decimals="2"
      id="ix_68_fact"
      unitRef="usdPershares">25.18</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c5"
      decimals="2"
      id="ix_69_fact"
      unitRef="usdPershares">0.16</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
      contextRef="c0"
      decimals="2"
      id="ix_70_fact"
      unitRef="usdPershares">0.48</us-gaap:InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare>
    <vavx:NetRealizedGainlossAndChangeInUnrealizedAppreciationdepreciationFromInvestmentsIn
      contextRef="c5"
      decimals="2"
      id="ix_71_fact"
      unitRef="usdPershares">9.21</vavx:NetRealizedGainlossAndChangeInUnrealizedAppreciationdepreciationFromInvestmentsIn>
    <vavx:NetRealizedGainlossAndChangeInUnrealizedAppreciationdepreciationFromInvestmentsIn
      contextRef="c0"
      decimals="2"
      id="ix_72_fact"
      unitRef="usdPershares">-2.27</vavx:NetRealizedGainlossAndChangeInUnrealizedAppreciationdepreciationFromInvestmentsIn>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c5"
      decimals="2"
      id="ix_73_fact"
      unitRef="usdPershares">9.37</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
      contextRef="c0"
      decimals="2"
      id="ix_74_fact"
      unitRef="usdPershares">-1.79</us-gaap:InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c5"
      decimals="2"
      id="ix_75_fact"
      unitRef="usdPershares">0.17</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:InvestmentCompanyDistributionToShareholdersPerShare
      contextRef="c0"
      decimals="2"
      id="ix_76_fact"
      unitRef="usdPershares">0.17</us-gaap:InvestmentCompanyDistributionToShareholdersPerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c2"
      decimals="2"
      id="ix_77_fact"
      unitRef="usdPershares">23.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:NetAssetValuePerShare
      contextRef="c2"
      decimals="2"
      id="ix_78_fact"
      unitRef="usdPershares">23.22</us-gaap:NetAssetValuePerShare>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c5" decimals="4" id="ix_79_fact" unitRef="pure">0.6777</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyTotalReturn contextRef="c0" decimals="4" id="ix_80_fact" unitRef="pure">-0.066</us-gaap:InvestmentCompanyTotalReturn>
    <us-gaap:InvestmentCompanyExpenseRatioBeforeIncentiveAllocation contextRef="c5" decimals="4" id="ix_81_fact" unitRef="pure">0.002</us-gaap:InvestmentCompanyExpenseRatioBeforeIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioBeforeIncentiveAllocation contextRef="c0" decimals="4" id="ix_82_fact" unitRef="pure">0.002</us-gaap:InvestmentCompanyExpenseRatioBeforeIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation contextRef="c5" decimals="4" id="ix_83_fact" unitRef="pure">0.002</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation contextRef="c0" decimals="4" id="ix_84_fact" unitRef="pure">0.0018</us-gaap:InvestmentCompanyExpenseRatioAfterIncentiveAllocation>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio contextRef="c5" decimals="4" id="ix_85_fact" unitRef="pure">0.0423</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:InvestmentCompanyInvestmentIncomeLossRatio contextRef="c0" decimals="4" id="ix_86_fact" unitRef="pure">0.0376</us-gaap:InvestmentCompanyInvestmentIncomeLossRatio>
    <us-gaap:SubsequentEventsTextBlock contextRef="c0" id="ixv-2480">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;b&gt;Note 9. Subsequent Event Review&lt;/b&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;On October 5, 2026, the Trust declared a distribution
of $0.2233 per share to shareholders of record on October 6, 2026, payable on October 7, 2026. The Trust has evaluated subsequent
events and transactions for potential recognition or disclosure through the date the financial statements were issued and has determined
that there are no other material events that require disclosure in the financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:DividendsPayableDateDeclaredDayMonthAndYear contextRef="c36" id="ixv-3854">2026-10-05</us-gaap:DividendsPayableDateDeclaredDayMonthAndYear>
    <us-gaap:DividendsPayableAmountPerShare
      contextRef="c35"
      decimals="4"
      id="ixv-3855"
      unitRef="usdPershares">0.2233</us-gaap:DividendsPayableAmountPerShare>
    <us-gaap:DividendsPayableDateOfRecordDayMonthAndYear contextRef="c36" id="ixv-3856">2026-10-06</us-gaap:DividendsPayableDateOfRecordDayMonthAndYear>
    <us-gaap:DividendPayableDateToBePaidDayMonthAndYear contextRef="c36" id="ixv-3857">2026-10-07</us-gaap:DividendPayableDateToBePaidDayMonthAndYear>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c5" id="ixv-3858">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c5" id="ixv-3859">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c5" id="ixv-3860">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c5" id="ixv-3861">false</ecd:Rule10b51ArrAdoptedFlag>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="c0" id="hidden-fact-0">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:CommonStockSharesAuthorizedUnlimited contextRef="c4" id="hidden-fact-1">Unlimited</us-gaap:CommonStockSharesAuthorizedUnlimited>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c0"
      decimals="INF"
      id="hidden-fact-2"
      unitRef="Segment">1</us-gaap:NumberOfOperatingSegments>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-3867">0002060717</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c0" id="ixv-3868">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="c0" id="ixv-3869">Q3</dei:DocumentFiscalPeriodFocus>
    <dei:CurrentFiscalYearEndDate contextRef="c0" id="ixv-3870">--12-31</dei:CurrentFiscalYearEndDate>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#ix_14_fact"
          xlink:label="ix_14_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_9_fact"
          xlink:label="ix_9_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_24_fact"
          xlink:label="ix_24_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_27_fact"
          xlink:label="ix_27_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_15_fact"
          xlink:label="ix_15_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_20_fact"
          xlink:label="ix_20_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_26_fact"
          xlink:label="ix_26_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_18_fact"
          xlink:label="ix_18_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_0_fact"
          xlink:label="ix_0_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_11_fact"
          xlink:label="ix_11_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_22_fact"
          xlink:label="ix_22_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_8_fact"
          xlink:label="ix_8_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_19_fact"
          xlink:label="ix_19_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_12_fact"
          xlink:label="ix_12_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_4_fact"
          xlink:label="ix_4_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_21_fact"
          xlink:label="ix_21_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_7_fact"
          xlink:label="ix_7_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_5_fact"
          xlink:label="ix_5_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_1_fact"
          xlink:label="ix_1_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_16_fact"
          xlink:label="ix_16_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_6_fact"
          xlink:label="ix_6_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_2_fact"
          xlink:label="ix_2_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_13_fact"
          xlink:label="ix_13_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_3_fact"
          xlink:label="ix_3_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_25_fact"
          xlink:label="ix_25_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_17_fact"
          xlink:label="ix_17_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_10_fact"
          xlink:label="ix_10_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_23_fact"
          xlink:label="ix_23_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_0_footnote" xlink:label="ix_0_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_14_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_9_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_24_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_27_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_15_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_20_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_26_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_18_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_0_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_11_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_22_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_8_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_19_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_12_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_4_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_21_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_7_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_5_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_1_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_16_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_6_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_2_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_13_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_3_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_25_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_17_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_10_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_23_fact"
          xlink:to="ix_0_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_31_fact"
          xlink:label="ix_31_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_36_fact"
          xlink:label="ix_36_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_39_fact"
          xlink:label="ix_39_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_29_fact"
          xlink:label="ix_29_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_28_fact"
          xlink:label="ix_28_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_37_fact"
          xlink:label="ix_37_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_34_fact"
          xlink:label="ix_34_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_46_fact"
          xlink:label="ix_46_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_41_fact"
          xlink:label="ix_41_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_33_fact"
          xlink:label="ix_33_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_45_fact"
          xlink:label="ix_45_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_32_fact"
          xlink:label="ix_32_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_47_fact"
          xlink:label="ix_47_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_40_fact"
          xlink:label="ix_40_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_30_fact"
          xlink:label="ix_30_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_38_fact"
          xlink:label="ix_38_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_42_fact"
          xlink:label="ix_42_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_43_fact"
          xlink:label="ix_43_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_35_fact"
          xlink:label="ix_35_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_44_fact"
          xlink:label="ix_44_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_1_footnote" xlink:label="ix_1_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font-weight: normal">No comparative financial statements have been provided as the Trust did not have any operations
as of September 30, 2025.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_31_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_36_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_39_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_29_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_28_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_37_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_34_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_46_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_41_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_33_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_45_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_32_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_47_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_40_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_30_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_38_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_42_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_43_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_35_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_44_fact"
          xlink:to="ix_1_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_48_fact"
          xlink:label="ix_48_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_2_footnote" xlink:label="ix_2_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes 1,588,636.97 of staked avalanche.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_48_fact"
          xlink:to="ix_2_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_50_fact"
          xlink:label="ix_50_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_49_fact"
          xlink:label="ix_49_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_3_footnote" xlink:label="ix_3_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Trust did not hold any AVAX as of November 20, 2025 (Date of Seeding).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_50_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_49_fact"
          xlink:to="ix_3_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_56_fact"
          xlink:label="ix_56_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_52_fact"
          xlink:label="ix_52_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_54_fact"
          xlink:label="ix_54_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_51_fact"
          xlink:label="ix_51_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_62_fact"
          xlink:label="ix_62_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_65_fact"
          xlink:label="ix_65_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_55_fact"
          xlink:label="ix_55_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_64_fact"
          xlink:label="ix_64_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_63_fact"
          xlink:label="ix_63_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_57_fact"
          xlink:label="ix_57_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_59_fact"
          xlink:label="ix_59_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_58_fact"
          xlink:label="ix_58_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_60_fact"
          xlink:label="ix_60_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_61_fact"
          xlink:label="ix_61_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_53_fact"
          xlink:label="ix_53_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_66_fact"
          xlink:label="ix_66_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_4_footnote" xlink:label="ix_4_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">No comparative share activity have been provided as the Trust did not have any operations
as of September 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_56_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_52_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_54_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_51_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_62_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_65_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_55_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_64_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_63_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_57_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_59_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_58_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_60_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_61_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_53_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_66_fact"
          xlink:to="ix_4_footnote"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#ix_67_fact"
          xlink:label="ix_67_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_77_fact"
          xlink:label="ix_77_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_82_fact"
          xlink:label="ix_82_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_76_fact"
          xlink:label="ix_76_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_68_fact"
          xlink:label="ix_68_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_74_fact"
          xlink:label="ix_74_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_80_fact"
          xlink:label="ix_80_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_71_fact"
          xlink:label="ix_71_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_81_fact"
          xlink:label="ix_81_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_79_fact"
          xlink:label="ix_79_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_69_fact"
          xlink:label="ix_69_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_73_fact"
          xlink:label="ix_73_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_78_fact"
          xlink:label="ix_78_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_86_fact"
          xlink:label="ix_86_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_84_fact"
          xlink:label="ix_84_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_83_fact"
          xlink:label="ix_83_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_85_fact"
          xlink:label="ix_85_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_70_fact"
          xlink:label="ix_70_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_72_fact"
          xlink:label="ix_72_fact"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#ix_75_fact"
          xlink:label="ix_75_fact"
          xlink:type="locator"/>
        <link:footnote id="ix_5_footnote" xlink:label="ix_5_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: 8pt Times New Roman, Times, Serif">No prior comparative financial statements have been provided as the Trust did not have any operations as of September 30, 2025.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_67_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_77_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_82_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_76_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_68_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_74_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_80_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_71_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_81_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_79_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_69_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_73_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_78_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_86_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_84_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_83_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_85_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_70_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_72_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_75_fact"
          xlink:to="ix_5_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_6_footnote" xlink:label="ix_6_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: 8pt Times New Roman, Times, Serif">Net investment income per share has been calculated based upon an average of daily shares outstanding.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_70_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_69_fact"
          xlink:to="ix_6_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_7_footnote" xlink:label="ix_7_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: 8pt Times New Roman, Times, Serif">The amount shown for a share outstanding throughout the period may not agree with the change in the aggregate gains and losses for the period because of the timing of sales and repurchases of the Trust&#x2019;s shares in relation to fluctuating market values of AVAX.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_72_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_71_fact"
          xlink:to="ix_7_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_8_footnote" xlink:label="ix_8_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: 8pt Times New Roman, Times, Serif">Returns are not annualized and include adjustments required by GAAP. Returns for financial statements purposes may differ from net asset values and performance reported elsewhere by the Trust.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_80_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_79_fact"
          xlink:to="ix_8_footnote"
          xlink:type="arc"/>
        <link:footnote id="ix_9_footnote" xlink:label="ix_9_footnote" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US"><xhtml:span style="font: 8pt Times New Roman, Times, Serif">Annualized.</xhtml:span></link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_82_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_84_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_85_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_86_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_83_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="ix_81_fact"
          xlink:to="ix_9_footnote"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
